Control of energy homeostasis: role of enzymes and intermediates of fatty acid metabolism in the central nervous system.

The regulation of energy homeostasis is critical for normal physiology and survival. Energy flux must be rigorously monitored and adjusted to ensure that fuel intake and expenditure remain within acceptable limits. The central nervous system (CNS) is, in large part, responsible for conducting this energy-monitoring function and for integrating the numerous inputs. It has become evident that neurons of the CNS monitor and respond to levels of metabolic intermediates that reflect peripheral energy status. Intermediates in the fatty acid biosynthetic pathway have been implicated as hypothalamic signaling mediators that sense and respond to changes in circulating fuels. Genetic and pharmacologic manipulation of the enzymes of fatty acid metabolism have led to the hypothesis that neuronal metabolic intermediates affect neural outputs that modify both feeding behavior and energy expenditure. This review focuses on the regulatory roles of these enzymes and intermediates in the regulation of food intake and energy balance.

[1]  T. Shimokawa,et al.  The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Prentki,et al.  A Role for Hypothalamic Malonyl-CoA in the Control of Food Intake* , 2005, Journal of Biological Chemistry.

[3]  M. Lane,et al.  Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Thorsten Buch,et al.  Agouti-related peptide–expressing neurons are mandatory for feeding , 2005, Nature Neuroscience.

[5]  P. A. Wood,et al.  Homozygous carnitine palmitoyltransferase 1b (muscle isoform) deficiency is lethal in the mouse. , 2005, Molecular genetics and metabolism.

[6]  N. Maeda,et al.  Endogenous Production of Lipoic Acid Is Essential for Mouse Development , 2005, Molecular and Cellular Biology.

[7]  M. Miyazaki,et al.  Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Ziwei Gu,et al.  Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Means,et al.  The Ca2+/Calmodulin-dependent Protein Kinase Kinases Are AMP-activated Protein Kinase Kinases* , 2005, Journal of Biological Chemistry.

[10]  L. E. Hammond,et al.  Mitochondrial Glycerol-3-phosphate Acyltransferase-1 Is Essential in Liver for the Metabolism of Excess Acyl-CoAs* , 2005, Journal of Biological Chemistry.

[11]  R. Heath,et al.  Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. , 2005, Cell metabolism.

[12]  A. Edelman,et al.  Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. , 2005, Cell metabolism.

[13]  L. E. Hammond,et al.  Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. , 2005, Cell metabolism.

[14]  Tiffany A. Miller,et al.  Insulin acutely decreases hepatic fatty acid synthase activity. , 2005, Cell metabolism.

[15]  M. Lane,et al.  From multipotent stem cell to adipocyte. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[16]  M. Lane,et al.  Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. , 2005, Annual review of biochemistry.

[17]  J. Schneider,et al.  "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.

[18]  T. Horvath,et al.  Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia. , 2005, Cell metabolism.

[19]  M. Lane,et al.  Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Chirala,et al.  Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Porte,et al.  Diabetes, Obesity, and the Brain , 2005, Science.

[22]  G. Hjälm,et al.  The 5′-AMP-activated Protein Kinase γ3 Isoform Has a Key Role in Carbohydrate and Lipid Metabolism in Glycolytic Skeletal Muscle* , 2004, Journal of Biological Chemistry.

[23]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[24]  M. Steinmetz,et al.  Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5'AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique. , 2004, European journal of biochemistry.

[25]  J. Clapham,et al.  Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis Published, JLR Papers in Press, April 21, 2004. DOI 10.1194/jlr.M400010-JLR200 , 2004, Journal of Lipid Research.

[26]  G. Ronnett,et al.  Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. , 2004, American journal of physiology. Endocrinology and metabolism.

[27]  G. Ronnett,et al.  C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase* , 2004, Journal of Biological Chemistry.

[28]  D. Hardie,et al.  AMP-Activated Protein Kinase: A Master Switch in Glucose and Lipid Metabolism , 2004, Reviews in Endocrine and Metabolic Disorders.

[29]  M. Lane,et al.  Long-term effects of a fatty acid synthase inhibitor on obese mice: food intake, hypothalamic neuropeptides, and UCP3. , 2004, Biochemical and biophysical research communications.

[30]  A. G. Roseberry,et al.  Rapid Rewiring of Arcuate Nucleus Feeding Circuits by Leptin , 2004, Science.

[31]  M. Birnbaum,et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.

[32]  D. Carling,et al.  AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* , 2004, Journal of Biological Chemistry.

[33]  M. Miyazaki,et al.  Regulation of stearoyl-CoA desaturases and role in metabolism. , 2004, Progress in lipid research.

[34]  N. Socci,et al.  Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. , 2004, The Journal of clinical investigation.

[35]  R. Huganir,et al.  C75, a Fatty Acid Synthase Inhibitor, Modulates AMP-activated Protein Kinase to Alter Neuronal Energy Metabolism* , 2004, Journal of Biological Chemistry.

[36]  Peter Schjerling,et al.  Knockout of the α2 but Not α1 5′-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle* , 2004, Journal of Biological Chemistry.

[37]  David Carling,et al.  Supplemental Data LKB 1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade , 2003 .

[38]  M. Lane,et al.  Hypothalamic malonyl-CoA as a mediator of feeding behavior , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Jérôme Boudeau,et al.  Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade , 2003, Journal of biology.

[40]  C. Mobbs,et al.  The fatty acid synthase inhibitor cerulenin and feeding, like leptin, activate hypothalamic pro-opiomelanocortin (POMC) neurons , 2003, Brain Research.

[41]  S. Wakil,et al.  Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  N. Huijkman,et al.  Cloning and expression of the liver and muscle isoforms of ovine carnitine palmitoyltransferase 1: residues within the N-terminus of the muscle isoform influence the kinetic properties of the enzyme. , 2003, The Biochemical journal.

[43]  Roberto Conti,et al.  Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production , 2003, Nature Medicine.

[44]  S. Chirala,et al.  Fatty acid synthesis is essential in embryonic development: Fatty acid synthase null mutants and most of the heterozygotes die in utero , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Woods,et al.  C75 inhibits food intake by increasing CNS glucose metabolism , 2003, Nature Medicine.

[46]  M. Lane,et al.  Effect of the anorectic fatty acid synthase inhibitor C75 on neuronal activity in the hypothalamus and brainstem , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. E. Hammond,et al.  Mitochondrial Glycerol-3-Phosphate Acyltransferase-Deficient Mice Have Reduced Weight and Liver Triacylglycerol Content and Altered Glycerolipid Fatty Acid Composition , 2002, Molecular and Cellular Biology.

[48]  R. Seeley,et al.  Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion. , 2002, Diabetes.

[49]  C. Townsend,et al.  Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. , 2002, American journal of physiology. Endocrinology and metabolism.

[50]  Nigel Price,et al.  A novel brain-expressed protein related to carnitine palmitoyltransferase I. , 2002, Genomics.

[51]  B. Yandell,et al.  Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  N. Socci,et al.  Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss , 2002, Science.

[53]  D. Macneil,et al.  Neither Agouti-Related Protein nor Neuropeptide Y Is Critically Required for the Regulation of Energy Homeostasis in Mice , 2002, Molecular and Cellular Biology.

[54]  G. Ronnett,et al.  C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  K. Petersen,et al.  Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.

[56]  M. Reitman,et al.  Leptin-replacement therapy for lipodystrophy. , 2002, The New England journal of medicine.

[57]  Monica V. Kumar,et al.  Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Zhaohui Feng,et al.  Central administration of oleic acid inhibits glucose production and food intake. , 2002, Diabetes.

[59]  Monica V. Kumar,et al.  Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Mobbs,et al.  Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting. , 2001, Diabetes.

[61]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[62]  A. Kawaguchi,et al.  [Fatty acid synthase]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[63]  Rüdiger Klein,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[64]  M. Prentki,et al.  Activation of Malonyl-CoA Decarboxylase in Rat Skeletal Muscle by Contraction and the AMP-activated Protein Kinase Activator 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside* , 2000, The Journal of Biological Chemistry.

[65]  C. Townsend,et al.  Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. , 2000, Science.

[66]  J. Sundberg,et al.  Asebia-2J (Scd1(ab2J)): a new allele and a model for scarring alopecia. , 2000, The American journal of pathology.

[67]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[68]  C. Townsend,et al.  Synthesis and antitumor activity of an inhibitor of fatty acid synthase , 2000 .

[69]  A. Prentice,et al.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.

[70]  J. Friedman,et al.  Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[71]  H. Morkoç,et al.  On the incorporation of Mg and the role of oxygen, silicon, and hydrogen in GaN prepared by reactive molecular beam epitaxy , 1997 .

[72]  P. Watkins Fatty acid activation. , 1997, Progress in lipid research.

[73]  D. Yarnall,et al.  Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B). , 1997, Genomics.

[74]  R. Palmiter,et al.  Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.

[75]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[76]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[77]  B. Kahn,et al.  Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. , 1993, The Journal of biological chemistry.

[78]  S. Wakil,et al.  Fatty acid synthase, a proficient multifunctional enzyme. , 1989, Biochemistry.

[79]  M. Lane,et al.  Kinetics of activation of acetyl-CoA carboxylase by citrate. Relationship to the rate of polymerization of the enzyme. , 1983, The Journal of biological chemistry.

[80]  J. McGarry,et al.  Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. , 1978, The Journal of biological chemistry.

[81]  J. McGarry,et al.  A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. , 1977, The Journal of clinical investigation.

[82]  M. Lane,et al.  Liver acetyl CoA carboxylase: insight into the mechanism of activation by tricarboxylic acids and acetyl CoA. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[83]  M. Lane,et al.  Molecular characteristics of liver acetyl CoA carboxylase. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Pevsner,et al.  X-Linked Adrenoleukodystrophy: Genes, Mutations, and Phenotypes , 2004, Neurochemical Research.

[85]  D. Hardie,et al.  Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. , 1997, Journal of applied physiology.

[86]  J. Ntambi,et al.  The regulation of stearoyl-CoA desaturase (SCD). , 1995, Progress in lipid research.

[87]  D. Hardie Regulation of fatty acid synthesis via phosphorylation of acetyl-CoA carboxylase. , 1989, Progress in lipid research.

[88]  M. Lane,et al.  Tricarboxylic acid cycle intermediates and the control of fatty acid synthesis and ketogenesis. , 1981, Current topics in cellular regulation.

[89]  J. McGarry,et al.  Regulation of hepatic fatty acid oxidation and ketone body production. , 1980, Annual review of biochemistry.

[90]  J. Moss,et al.  The biotin-dependent enzymes. , 1971, Advances in enzymology and related areas of molecular biology.